VOICED : EEUU comienza a aplicar vacunas contra el covid-19 de Pfizer a ninos de 5 a 11 anos

The video discusses the initiation of COVID-19 vaccination for children aged 5 to 11 in the US. The CDC and FDA have approved the Pfizer-BioNTech vaccine for this age group. The first doses were administered in Connecticut, marking a step towards normalcy for families. The vaccine is given in two doses of 10 micrograms each, showing a 90.7% efficacy in preventing symptomatic COVID-19. Vaccination is expected to reduce school closures and transmission rates.

Which organization recommended the Pfizer-BioNTech vaccine for children aged 5 to 11?

• National Institutes of Health (NIH)

• American Medical Association (AMA)

• Centers for Disease Control and Prevention (CDC)

• World Health Organization (WHO)

What activity can children resume after receiving the vaccine?

• Attending school without masks

• Traveling internationally

• Going to sports events and movies

• Visiting amusement parks

How many micrograms are in each dose of the vaccine for children aged 5 to 11?

• 30 micrograms

• 20 micrograms

• 10 micrograms

• 5 micrograms

What is the reported efficacy of the Pfizer vaccine in preventing symptomatic COVID-19 in children?

• 85.5%

• 90.7%

• 95.2%

• 99.9%

What additional benefit is expected from vaccinating children besides preventing illness?

• Mandatory vaccination for all age groups

• Elimination of all COVID-19 variants

• Fewer class closures and reduced transmission

• Increased school funding